Translational Medicine Group People
 |
|
Mason Freeman Director
Education BA, Harvard; MD, UC San Francisco
Interests
See ccib.mgh.harvard.edu/founders-freeman on this site for information on Dr. Freeman.
|
| |
 |
|
Yuan-Di Halvorsen Clinical Project Leader
Education PhD, U. of Kentucky
Interests
Dr. Halvorsen co-founded two biotech companies with platform technologies in cell-based therapies and target identification processes using primary human adipose stromal cells. She was instrumental in building a GMP facility to manufacture human primary cells for tissue repair. Recently she has focused on clinical research for oncology, and has directed a number of human phase I and multi-center phase II clinical trials.
|
| |
 |
|
Priya Mabry Administrative Assistant, Clinical Project Coordinator
Education U. of Toronto
Interests Travel, reading and naps
My prior research experience was in nutrition and public health issues such as AIDS and substance abuse. My current work is fascinating because of its potential impact on diabetes.
|
| |
 |
|
Barbara Mahoney Clinical Trials Coordinator
Education RN, Mt. Auburn Hospital; Certified Clinical Research Coordinator
Interests Travel, reading, and my grandchildren
I have been a nurse at MGH for 27 years. I did clinical trials with our Rheumatology Department for five years and have worked with anticoagulation management for the last 9+ years. I feel both of these experiences will be of value for my current study work. |
| |
 |
|
Geoff Stilwell Research Project Leader
Education PhD, U. of Wisconsin
Interests Swimming, biking and jazz
I was in the biotech sector for eight years as a project leader and senior scientist prior to joining MGH. I am trained as a toxicologist and my background includes disease model development and small molecule discovery for neurological diseases. My work in the Translational Medicine Group focuses on preclinical development of drug candidates and biomaterials. |
| |
|
